Giulio Marchesini

Zitiert von

	Alle	Seit 2018
Zitate	80469	37153
h-index	111	74
i10-index	406	281

8000

4000

2000

6000

1999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023215 241 298 489 672 1057 1339 1602 1870 1993 2210 2533 2833 2938 3118 3400 3545 4836 5304 5932 6066 7023 7578 7564 2940

Öffentlicher Zugriff

Alle anzeigen

32 Artikel

4 Artikel

verfügbar

nicht verfügbar

Basierend auf Fördermandaten

Koautoren

Giampaolo BianchiUniversità di BolognaBestätigte E-Mail-Adresse bei unibo.it
Riccardo Dalle GraveVilla Garda Hospital, Department of Eating and Weight DisordersBestätigte E-Mail-Adresse bei adacentroobesitaanoressia.it
Salvatore PettaRicercatore di Gastroenterologia, Università di PalermoBestätigte E-Mail-Adresse bei unipa.it
Maria Letizia PetroniUniversity of BolognaBestätigte E-Mail-Adresse bei unibo.it
Antonio CraxiFull Professor of Gastroenterology and Internal Medicine, PROMISE, University of Palermo, ItalyBestätigte E-Mail-Adresse bei unipa.it
Calogero CammàSection of Gastroenterology, University of PalermoBestätigte E-Mail-Adresse bei unipa.it
Luca ValentiAssociate Professor of Internal Medicine, Università degli Studi di Milano, Fondazione Ca' GrandaBestätigte E-Mail-Adresse bei unimi.it
C DayNewcastle UniversityBestätigte E-Mail-Adresse bei ncl.ac.uk
Licata AnnaAssociate Professor of Internal MedicineBestätigte E-Mail-Adresse bei unipa.it
Zobair YounossiInova Health SystemBestätigte E-Mail-Adresse bei cldq.org
Marwan El GhochProfessor in Clinical Nutrition, Department of Nutrition and Dietetics, Beirut Arab UniversityBestätigte E-Mail-Adresse bei bau.edu.lb
Helena Cortez-PintoClínica Universitária de Gastrenterologia, Faculdade de Medicina, Universidade de LisboaBestätigte E-Mail-Adresse bei medicina.ulisboa.pt
Luca MieleFondazione Pol. Univ. A. Gemelli IRCCS, Università Cattolica Sacro Cuore. RomaBestätigte E-Mail-Adresse bei policlinicogemelli.it
Amedeo LonardoMedicina Interna USL ModenaBestätigte E-Mail-Adresse bei ausl.mo.it
Amalia GastaldelliInstitute of Clinical PhysiologyBestätigte E-Mail-Adresse bei ifc.cnr.it
Compare AngeloUniversità di BergamoBestätigte E-Mail-Adresse bei unibg.it
Edoardo MannucciDirettore Agenzia Diabetologia, AOU Careggi, FirenzeBestätigte E-Mail-Adresse bei unifi.it
Giovanni TargherAssociate Professor of Endocrinology and Diabetes, University of VeronaBestätigte E-Mail-Adresse bei univr.it
Riccardo BonadonnaFull Professor of Endocrinology and Metabolism, University of Parma, ItalyBestätigte E-Mail-Adresse bei unipr.it
agostino colliDipartimento Medico Asst Lecco A.Manzoni Hospital Lecco ItalyBestätigte E-Mail-Adresse bei asst-lecco.it

Folgen

Giulio Marchesini

Professor of Medicine, University of Bologna

Bestätigte E-Mail-Adresse bei unibo.it

metabolism liver diabetes obesity


Titel Nach Zitationen sortieren Nach Jahr sortieren Nach Titel sortieren	Zitiert von Zitiert von	Jahr
Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes B Zinman, C Wanner, JM Lachin, D Fitchett, E Bluhmki, ... New England Journal of Medicine 373 (22), 2117-2128, 2015	10978	2015
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome G Marchesini, E Bugianesi, G Forlani, F Cerrelli, M Lenzi, R Manini, ... Hepatology 37 (4), 917-923, 2003	3470	2003
Empagliflozin and progression of kidney dsease in type 2 diabetes C Wanner, SE Inzucchi, JM Lachin, D Fitchett, M von Eynatten, ... New england journal of medicine 375 (4), 323-334, 2016	3382	2016
Nonalcoholic fatty liver disease: a feature of the metabolic syndrome G Marchesini, M Brizi, G Bianchi, S Tomassetti, E Bugianesi, M Lenzi, ... Diabetes 50 (8), 1844-1850, 2001	3281	2001
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD P Angulo, JM Hui, G Marchesini, E Bugianesi, J George, GC Farrell, ... Hepatology 45 (4), 846-854, 2007	3061	2007
Association of nonalcoholic fatty liver disease with insulin resistance G Marchesini, M Brizi, AM Morselli-Labate, G Bianchi, E Bugianesi, ... The American journal of medicine 107 (5), 450-455, 1999	2105	1999
EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease G Marchesini, CP Day, JF Dufour, A Canbay, V Nobili, V Ratziu, H Tilg, ... Journal of Hepatology 64 (6), 1388-1402, 2016	2051*	2016
EASL-EASD-EASO Clinical Practice Guidelines for the management of nonalcoholic fatty liver disease EA the Study of the Liver (EASL), EA the Study of Diabetes (EASD), ... Journal of Hepatology 64 (6), 1388-1402, 2016	2042*	2016
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease European Association for The Study of The Liver, ... Obesity facts 9 (2), 65-90, 2016	2042	2016
Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma E Bugianesi, N Leone, E Vanni, G Marchesini, F Brunello, P Carucci, ... Gastroenterology 123 (1), 134-140, 2002	1819	2002
Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study G Bedogni, L Miglioli, F Masutti, C Tiribelli, G Marchesini, S Bellentani Hepatology 42 (1), 44-52, 2005	1794	2005
A randomized, controlled trial of 3.0 mg of liraglutide in weight management X Pi‑Sunyer, A Astrup, K Fujioka, F Greenway, A Halpern, M Krempf, ... New England Journal of Medicine 373 (1), 11-22, 2015	1707	2015
A position statement on NAFLD/NASH based on the EASL 2009 special conference V Ratziu, S Bellentani, H Cortez-Pinto, C Day, G Marchesini Journal of hepatology 53 (2), 372-384, 2010	1361	2010
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030 C Estes, QM Anstee, MT Arias-Loste, H Bantel, S Bellentani, J Caballeria, ... Journal of hepatology 69 (4), 896-904, 2018	1134	2018
Insulin resistance: a metabolic pathway to chronic liver disease E Bugianesi, AJ McCullough, G Marchesini Hepatology 42 (5), 987-1000, 2005	1073	2005
Metformin in non-alcoholic steatohepatitis G Marchesini, G Bianchi, S Tomassetti, M Zoli, N Melchionda The Lancet 358 (9285), 893-894, 2001	1054	2001
Clinical features and natural history of nonalcoholic steatosis syndromes Y Falck-Ytter, ZM Younossi, G Marchesini, AJ McCullough Seminars in liver disease 21 (01), 017-026, 2001	984	2001
A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease E Bugianesi, E Gentilcore, R Manini, S Natale, E Vanni, N Villanova, ... The American journal of gastroenterology 100 (5), 1082, 2005	967	2005
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes AL Fracanzani, L Valenti, E Bugianesi, M Andreoletti, A Colli, E Vanni, ... Hepatology 48 (3), 792-798, 2008	837	2008
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019	807	2019

Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.

Artikel 1–20

Zitate pro Jahr

Doppelte Zitate

Zusammengeführte Zitate

Koautor hinzufügenKoautoren

Folgen

Zitiert von

Koautoren